ASSET | DATE | % RETURN |
---|---|---|
Renovaro Biosciences (RENB) | 9/14/2016 - 9/30/2016 | 243.75% |
Datasea (DTSS) | 9/14/2016 - 9/30/2016 | 120.25% |
Clearside Biomedical (CLSD) | 9/14/2016 - 9/30/2016 | 119.34% |
Sarepta Therapeutics (SRPT) | 9/14/2016 - 9/30/2016 | 107.12% |
Nova Lifestyle I (NVFY) | 9/14/2016 - 9/30/2016 | 106.25% |
Collegium Pharmaceutical (COLL) | 9/14/2016 - 9/30/2016 | 105.55% |
Alphatec (ATEC) | 9/14/2016 - 9/30/2016 | 95.83% |
Vivakor (VIVK) | 9/14/2016 - 9/30/2016 | 87.5% |
Cronos (CRON) | 9/14/2016 - 9/30/2016 | 68.63% |
Merus (MRUS) | 9/14/2016 - 9/30/2016 | 67.67% |
Processa Pharmaceuticals (PCSA) | 9/14/2016 - 9/30/2016 | 65.75% |
PTC Therapeutics (PTCT) | 9/14/2016 - 9/30/2016 | 64.82% |
Protagonist Therapeutics (PTGX) | 9/14/2016 - 9/30/2016 | 60.32% |
Astria Therapeutics (ATXS) | 9/14/2016 - 9/30/2016 | 55.56% |
Creative Realities (CREX) | 9/14/2016 - 9/30/2016 | 53.85% |
Eledon Pharmaceuticals (ELDN) | 9/14/2016 - 9/30/2016 | 53% |
Sobr Safe (SOBR) | 9/14/2016 - 9/30/2016 | 52.5% |
Summit Therapeutics (SMMT) | 9/14/2016 - 9/30/2016 | 50.82% |
OLB (OLB) | 9/14/2016 - 9/30/2016 | 50% |
Fubotv (FUBO) | 9/14/2016 - 9/30/2016 | 50% |
Rezolute (RZLT) | 9/14/2016 - 9/30/2016 | 45.95% |
ZEN Graphene Solutions (ZTEK) | 9/14/2016 - 9/30/2016 | 45.59% |
Bone Biologics (BBLG) | 9/14/2016 - 9/30/2016 | 45.23% |
Aurinia Pharmaceuticals (AUPH) | 9/14/2016 - 9/30/2016 | 43.33% |
Stereotaxis (STXS) | 9/14/2016 - 9/30/2016 | 42.62% |